April 23, 2020 / 4:59 PM / a month ago

BRIEF-Gilead Antiviral Drug Remdesivir Flops In First Trial - FT

April 23 (Reuters) -

* GILEAD ANTIVIRAL DRUG REMDESIVIR FLOPS IN FIRST TRIAL - FT

* CHINESE TRIAL SHOWED REMDESIVIR DID NOT IMPROVE PATIENTS’ CONDITION OR REDUCE THE PATHOGEN’S PRESENCE IN THE BLOODSTREAM - FT

* REMDESIVIR, HAS FLOPPED IN ITS FIRST RANDOMISED CLINICAL TRIAL, ACCORDING TO DRAFT DOCUMENTS PUBLISHED ACCIDENTALLY BY THE WHO - FT

* GILEAD WARNED THAT THE DRAFT DOCUMENT POSTED ACCIDENTALLY BY WHO INCLUDED “INAPPROPRIATE CHARACTERISATIONS OF THE STUDY”- FT Source text: on.ft.com/2Vxsc1c Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below